Back to search
FORWARD CAD IDE Study
Coronary Arterial Disease (CAD)
Clinicaltrials.gov:
J&J ID:
#CP 71886
Interested in this trial?
Subscribe or share this trial
Trials at a glance
Status
Enrolling
Condition
Coronary Arterial Disease (CAD)
Trial type
Interventional
Trial phase
N/A
Investigational
product
product
Intravascular Lithotripsy
Age
18+ years old
Biological sex
All
Placebo?
No
Trial start date
April 4, 2025
Trial end date
December 1, 2027
CT.gov ID
#NCT06662500
Share the trial ID with your doctor to see if trial participation is right for you. Participation depends on an independent medical assessment.
Countries:
- United Kingdom,
- United States
Loading...
Enrolling
Basildon, UK, United Kingdom, SS16 5NL
Enrolling
Dallas, Texas, United States, 75226
Enrolling
Plano, Texas, United States, 75093
Enrolling
Boston, Massachusetts, United States, 02215
Enrolling
Boston, Massachusetts, United States, 02115
Enrolling
Bristol, UK, United Kingdom, BS2 8ED
Enrolling
Nashville, Tennessee, United States, 37203
Enrolling
New York, New York, United States, 10032
Enrolling
Atlanta, Georgia, United States, 30322
Enrolling
Leicester, UK, United Kingdom, LE3 9QP
Enrolling
Hartford, Connecticut, United States, 06112
Enrolling
Houston, Texas, United States, 77030
Enrolling
Salt Lake City, Utah, United States, 84111
Enrolling
Leeds, UK, United Kingdom, LS1 3EX
Enrolling
New York, New York, United States, 10075
Enrolling
Boston, Massachusetts, United States, 02114
Enrolling
Washington D.C., District of Columbia, United States, 20010
Enrolling
Minneapolis, Minnesota, United States, 55407
Enrolling
Raleigh, North Carolina, United States, 27607
Enrolling
New York, New York, United States, 10016
Enrolling
Bellevue, Washington, United States, 98004
Enrolling
Atlanta, Georgia, United States, 30309
Enrolling
Portland, Oregon, United States, 97225
Enrolling
La Jolla, California, United States, 92037
Enrolling
Littleton, Colorado, United States, 80120
Enrolling
Roslyn, New York, United States, 11576
Enrolling
London, UK, United Kingdom, SW17 0RE
Enrolling
London, UK, United Kingdom, SE1 7EH
Enrolling
Seattle, Washington, United States, 98122
Enrolling
Gainesville, Florida, United States, 32605
Enrolling
Cincinnati, Ohio, United States, 45219
Enrolling
San Francisco, California, United States, 94143
Enrolling
Seattle, Washington, United States, 98195
Enrolling
York, Pennsylvania, United States, 17403
#
More than 50 sites in this region
#
More than 10 sites in this region
#
Less than 10 sites in this region
Individual sites
Access detailed information on the trial:
Clinical trials information
Key links
© Johnson & Johnson and its affiliates 2026
